Target intelligence / Profile preview

RNF185 antisense RNA 1 (RNF185-AS1)

Target
RNF185-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

RNF185 antisense RNA 1 (RNF185-AS1) is a long non-coding RNA (lncRNA) transcribed antisense to the RNF185 gene. As a non-coding transcript, RNF185-AS1 does not encode a protein but may play a regulatory role in gene expression. Recent research has shown that RNF185-AS1 is upregulated in papillary thyroid carcinoma and its increased expression promotes proliferation, migration, and invasion of cancer cells, suggesting it may contribute to tumor progression[4]. However, there are no approved drugs, biomarkers, or established therapeutic interventions directly targeting RNF185-AS1. Its activities are most likely exerted through modulating expression of target genes—either that of the sense RNF185 gene or others—in a manner typical of lncRNA-mediated regulation. Note: - The search results primarily detail RNF185 (the protein-coding E3 ubiquitin ligase; a classical therapeutic target) and not RNF185-AS1 (the lncRNA in question), except for one specific mention in cancer context[4]. - If the intention was to retrieve information on RNF185 (the protein-coding gene or its product), further clarification would yield a different answer with expanded therapeutic relevance.

Other names
RNF185-AS1lncRNA RNF185-AS1RNF185 antisense non-coding RNA 1
02

Biological functions

Regulation of gene expression (specifically, may regulate RNF185 or other genes via antisense mechanisms)Promotion of cell proliferation, migration, and invasion (shown in papillary thyroid carcinoma[4])
03

Disease associations

Cancer (implicated in papillary thyroid carcinoma[4])

Beyond the preview

Go deeper on RNF185 antisense RNA 1 (RNF185-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNF185 antisense RNA 1 (RNF185-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call